In a recent study published inThe Journal of Bone & Joint Surgery, researchers conducted a study of the occurrence and contributing factors of tendon failure to heal after rotator cuff repair surgery. Using magnetic resonance imaging, the researchers set out to determine whether or not most failures occur within 12 weeks after the procedure.
Here are fours points on their findings.
1. The average time for the occurrence of retears was 19.2 weeks.
2. One week after surgery, 17 percent of the patients were diagnosed with a recurrent tear.
3. There was a linear increase in retears during the first 26 weeks of surgery.
4. Retears generally occur within 6 to 26 weeks after rotator cuff repair surgery and a significant amount of these retears occur between 12 to 26 weeks.
Authors of the study included Joseph Iannotti, MD, PhD, of the Cleveland Clinic; Allen Deutsch, MD, of the Kelsey Seabold Clinic in Houston; Andrew Green, MD, of University Orthopaedics in Providence, R.I.; Sally Rudicel, MD, of Pfizer in Cambridge, Mass.; Jared Christensen, PhD, of Pfizer; Shannon Marraffino of Pfizer; and Scott Rodeo, MD of Hospital for Special Surgery in New York.
More Articles on Sports Medicine:
10 Orthopedic Surgeons Recently Treating Professional Athletes
Should Orthopedists Talk About Costs With Patients: 31% Do Regularly
Dr. Thomas Blasco: 5 Flaws in Surgical Quality Initiatives
Here are fours points on their findings.
1. The average time for the occurrence of retears was 19.2 weeks.
2. One week after surgery, 17 percent of the patients were diagnosed with a recurrent tear.
3. There was a linear increase in retears during the first 26 weeks of surgery.
4. Retears generally occur within 6 to 26 weeks after rotator cuff repair surgery and a significant amount of these retears occur between 12 to 26 weeks.
Authors of the study included Joseph Iannotti, MD, PhD, of the Cleveland Clinic; Allen Deutsch, MD, of the Kelsey Seabold Clinic in Houston; Andrew Green, MD, of University Orthopaedics in Providence, R.I.; Sally Rudicel, MD, of Pfizer in Cambridge, Mass.; Jared Christensen, PhD, of Pfizer; Shannon Marraffino of Pfizer; and Scott Rodeo, MD of Hospital for Special Surgery in New York.
More Articles on Sports Medicine:
10 Orthopedic Surgeons Recently Treating Professional Athletes
Should Orthopedists Talk About Costs With Patients: 31% Do Regularly
Dr. Thomas Blasco: 5 Flaws in Surgical Quality Initiatives